Introduction: Why Cancer Vaccines Are Back in Focus For decades, the concept of a cancer vaccine occupied an uncertain space in oncology. Early therapeutic cancer vaccine efforts frequently failed to demonstrate meaningful clinical benefit, leading to skepticism about whether the immune system could be reliably trained to recognize and eliminate tumors (1). This perception has shifted dramatically in recent years. Advances in tumor genomics, neoantigen discovery, and RNA del